Study at a glance
How can gene differences affect the vitamin D receptor?
This page compares studies of common differences in the gene that makes the vitamin D receptor. The receptor helps cells respond to vitamin D. Different gene changes may affect the shape of the receptor, how much is made, or how the cell handles the instructions for making it.
Did vitamin D receptor gene differences have consistent effects?
One gene difference, called FokI, can produce a shorter receptor. One study found that this shorter form worked more effectively with another protein involved in controlling genes. Another study found no significant difference between the receptor forms in its tests. Other gene differences affected how much receptor was made. Researchers also disagreed about whether some linked gene differences changed how long RNA messages carrying instructions for making the receptor lasted. A further gene difference may affect how small RNA molecules help control receptor production.
Does a vitamin D receptor gene difference predict a person’s health?
Common gene differences do not all act in the same way. Their effects can depend on the cells and tests used. Some widely studied markers may indicate nearby inherited changes rather than being the direct cause of an effect. The evidence does not support calling one version of the gene always stronger, better or worse. Laboratory differences do not automatically predict a person’s health outcome.
Read the full article below ↓Why common VDR polymorphisms do not all mean the same thing
Common variation in the vitamin D receptor gene is often discussed as though each named polymorphism directly changes receptor strength. The wider field of vitamin D genetics provides the population and inheritance context for interpreting these variants. That is too simple. Some variants alter the VDR protein itself, some sit in promoter regions that can change transcription, and others lie in linked 3′-region haplotypes where the measured marker may track regulatory behaviour without being the causal nucleotide.
The scientific task is therefore not to label one allele ‘good’ or ‘bad’, but to identify what molecular layer a variant can plausibly influence and how strong the direct functional evidence is.
FokI is unusual because it changes receptor length
The FokI start-codon polymorphism is mechanistically distinct from BsmI, ApaI and TaqI because it can change where translation begins in vitamin D receptors. The shorter receptor isoform lacks three N-terminal amino acids compared with the longer form.
Jurutka and colleagues found that the shorter isoform interacted more efficiently with transcription factor IIB and showed greater transactivation in their experimental systems. That provides a plausible protein-level mechanism for functional differences.
Why FokI cannot be called universally more active
Direct functional evidence is not uniform. Gross and colleagues compared FokI receptor variants across ligand binding, DNA binding, transcriptional dose-response and endogenous CYP24 induction and did not detect significant differences under their assay conditions.
This null result matters. It means the shorter FokI receptor should not be described as universally stronger. A more defensible interpretation is that FokI can influence receptor behaviour, but the magnitude and even detectability of that effect depend on assay design, transcriptional partners, target genes and cellular context.
Promoter variants can change how much receptor is made
Promoter polymorphisms operate through a different route. Variants in Cdx2: and GATA-associated regulatory regions can alter transcription-factor binding or promoter output, potentially changing VDR abundance rather than the amino-acid sequence of the receptor.
The Rotterdam functional work is important because it links promoter haplotypes to measurable differences in promoter activity. This is a distinct mechanism from FokI and should not be collapsed into a generic concept of ‘VDR sensitivity’.
BsmI, ApaI and TaqI belong to a linked 3′-region architecture
BsmI, ApaI and TaqI are widely studied, but they do not alter the VDR amino-acid sequence in the way FokI can. They occur in a region with strong linkage disequilibrium and are better interpreted as markers within larger 3′-region haplotypes.
Fang and colleagues found that specific 3′-UTR haplotypes were associated with lower VDR expression and altered mRNA decay in their functional systems. That supports the possibility that common 3′-region variation can influence receptor abundance.
The mRNA-stability evidence is genuinely contradictory
The stability mechanism is not settled across experimental systems. Durrin and colleagues directly tested common VDR 3′-UTR haplotypes and found no difference in reporter mRNA half-life.
That contradiction should not be erased. Different constructs, cell models and linked sequence backgrounds can produce different results. The safest conclusion is that 3′-region haplotypes may influence VDR expression or RNA handling in some contexts, but there is no basis for claiming one universal stability effect for every BsmI/ApaI/TaqI-defined haplotype.
rs739837 adds a microRNA-regulatory mechanism
Another form of 3′-UTR regulation involves microRNA binding. rs739837 lies within a region capable of interacting with miR-885-3p. Functional reporter and protein-expression experiments support regulation of VDR through this microRNA context.
However, disease-specific studies have not produced one universal direction of clinical effect. The variant therefore illustrates a mechanistic possibility rather than a fixed prediction that one allele always increases or decreases vitamin D signalling.
What the functional evidence actually supports
- FokI can change VDR protein length and influence interaction with transcriptional machinery.
- FokI effects are context dependent and are not uniformly detected across classical assays.
- Promoter polymorphisms can alter VDR transcription and receptor abundance.
- BsmI, ApaI and TaqI are best interpreted within linked 3′-region regulatory haplotypes rather than as independent protein-changing variants.
- 3′-UTR effects on mRNA stability are inconsistent across experimental systems.
- MicroRNA-associated variants can add another regulatory layer, but their direction should not be universalised.
These distinctions matter because common VDR polymorphisms can alter different steps in the signalling chain, reinforcing why vitamin D status and vitamin D effect are not interchangeable concepts. A variant that changes receptor abundance is not mechanistically equivalent to one that changes receptor protein structure, and neither should be treated as automatically predictive of clinical outcome.
Primary evidence and publication details
Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14:401-420.
Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res. 1998;13:1691-1699.
Fang Y, van Meurs JBJ, d’Alesio A, et al. Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study. Am J Hum Genet. 2005;77:807-823.
Durrin LK, Haile RW, Ingles SA, Coetzee GA. Vitamin D receptor 3′-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta. 1999;1453:311-320.
Ji X, Mao J, Zhou S. Rs739837 Polymorphism in MiR-885-3p Binding Site Within 3′-Untranslated Region of Vitamin D Receptor is Associated with a Decreased Risk of Pressure Ulcers. Cell Physiol Biochem. 2017;44:2129-2137.
Related reading
Differential and Overlapping Effects of 20,23(OH)2D3 and 1,25(OH)2D3 on Gene Expression in Human Epidermal Keratinocytes: Identification of AhR as an Alternative Receptor for 20,23(OH)2D3
A novel pathway of vitamin D activation by CYP11A has previously been elucidated.
Original paper ↗Read more →Effects of Lactobacillus acidophilus and Bifidobacterium bifidum probiotics on the serum biochemical parameters, and the vitamin D and leptin receptor genes on mice colon cancer
Then, the serum total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), alanine transaminase, alkaline phosphatase, and albumin and also VDR and LPR genes expression were evaluated.
Original paper ↗Read more →Evolution of Vitamin D Status and Vitamin D Receptor Gene Expression Among Professional Handball Athletes During a Competitive Period. Relationship with Body Composition, Calcium, Magnesium and Phosphorous
Introduction: A generalized risk of vitamin D deficiency exists worldwide affecting also professional and elite athletes.
Original paper ↗Read more →Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with increasing prevalence worldwide.
Original paper ↗Read more →Improvement in the Immunity: and Vitamin D3-Activity-Related Gene Expression of Coccidiosis-Challenged Ross 708 Broilers in Response to the In Ovo Injection of 25-Hydroxyvitamin D3 †
Effects of the in ovo administration of two vitamin D3 sources (vitamin D3 (D3) and 25-hydroxyvitamin D3 (25OHD3)) on the expression of D3 activity: and immunity-related genes in broilers subjected to a coccidiosis infection were investigated.
Original paper ↗Read more →Osteoblast-Specific Transcription Factor Osterix Increases Vitamin D Receptor Gene Expression in Osteoblasts
For example, calvaria obtained from Osx-null embryos displayed dramatic reductions in VDR expression compared to wild-type calvaria.
Original paper ↗Read more →Regulation of somatostatin expression by vitamin D3 and valproic acid in human adipose-derived mesenchymal stem cells
Therefore, the aim of this study was to investigate the role of vitamin D3 machinery and its metabolic enzymes in ADMSC.
Original paper ↗Read more →The association between body mass index elevation and differentiation in vitamin D receptor gene expression, genetic polymorphism, and oxidative stress in adult Egyptian individuals
Vitamin D plays a central role in maintaining calcium, phosphorus, and bone homeostasis in close interaction with the parathyroid hormone.
Original paper ↗Read more →The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: randomized controlled trial
The objective of this randomised controlled study is to examine the effect of vitamin D supplementation on body composition and the expression of the vitamin D receptor (VDR) mRNA.
Original paper ↗Read more →The role of 25-hydroxyvitamin-D3 and vitamin D receptor gene in human periodontal ligament fibroblasts as response to orthodontic compressive strain: an in vitro study
A pool of hPDL fibroblasts was treated in absence or presence of 25(OH)D3 in 3 different concentrations (10, 40 and 60 ng/ml).
Original paper ↗Read more →Variants in the VDR Gene May Influence 25(OH)D Levels in Type 1 Diabetes Mellitus in a Brazilian Population
This study aimed to evaluate the association of four variants in the VDR gene (rs7975232, rs1544410, rs731236, and rs2228570) with T1DM risk and vitamin D levels within a population from North Region, Brazil, as well as the influence of genomic ancestry on T1DM.
Original paper ↗Read more →VDR, SOD-2, and CYP24A1 Gene Expression in Different Genotypes of BsmI SNP of the Vitamin D Receptor Gene in Individuals with Hypovitaminosis
Objective: To evaluate the effect of the genotypes of BsmI single nucleotide polymorphism (SNP) of the VDR gene on VDR, SOD2, and CYP24A1 gene expression in individuals with low serum vitamin D levels.
Original paper ↗Read more →Vitamin D Receptor Gene Ablation in the Conceptus Has Limited Effects on Placental Morphology, Function and Pregnancy Outcome
Vitamin D deficiency has been implicated in the pathogenesis of several pregnancy complications attributed to impaired or abnormal placental function, but there are few clues indicating the mechanistic role of vitamin D in their pathogenesis.
Original paper ↗Read more →Without 1α-hydroxylation, the gene expression profile of 25(OH)D3 treatment overlaps deeply with that of 1,25(OH)2D3 in prostate cancer cells
Recently, the antiproliferative action of 1,25(OH)2D3 (1,25D3), an active metabolite of vitamin D3, in the management of prostate cancer has been argued rigorously.
Original paper ↗Read more →Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation
Vitamin D receptor (VDR) is present in multiple blood cells, and the hormonal form of vitamin D, 1,25-dihydroxyvitamin D (1,25D) is essential for the proper functioning of the immune system.
Original paper ↗Read more →Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors
This study aimed to investigate the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Original paper ↗Read more →Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors
This study aimed to investigate the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Original paper ↗Read more →Vitamin D Receptor Gene Expression and Function in a South African Population: Ethnicity, Vitamin D and FokI
Polymorphisms of the vitamin D receptor gene (VDR) have been associated inconsistently with various diseases, across populations of diverse origin.
Original paper ↗Read more →Vitamin D Receptor Gene Expression in Adipose Tissue of Obese Individuals is Regulated by miRNA and Correlates with the Pro-Inflammatory Cytokine Level
Results: VDR mRNA levels were higher, while CYP27B1 levels were lower in adipose tissues of obese patients than in those of normal-weight controls (VAT: P = 0.04, SAT: P < 0.0001 and VAT: P = 0.004, SAT: P = 0.016, respectively).
Original paper ↗Read more →BsmI, ApaI and TaqI Polymorphisms in the Vitamin D Receptor Gene (VDR) and Association with Lumbar Spine Pathologies: An Italian Case-Control Study
We aimed to evaluate the distribution of VDR BsmI, ApaI, and TaqI allele, genotype, and haplotype frequencies in an Italian cohort of 266 patients with lumbar spine disorders assessed by Magnetic Resonance Imaging and 252 asymptomatic controls.
Original paper ↗Read more →Vitamin D Receptors
A physiology-first explanation of vitamin D receptors, covering cellular detection, transcriptional regulation, signalling integration, and tissue-specific responsiveness.
Read more →Original sources
The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB
Published in Mol Endocrinol (2000).
Publication details
Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14:401-420.
The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants
Published in J Bone Miner Res (1998).
Publication details
Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res. 1998;13:1691-1699.
Promoter and 3'-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study
Published in Am J Hum Genet (2005).
Publication details
Fang Y, van Meurs JBJ, d’Alesio A, et al. Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study. Am J Hum Genet. 2005;77:807-823.
Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability
Published in Biochim Biophys Acta (1999).
Publication details
Durrin LK, Haile RW, Ingles SA, Coetzee GA. Vitamin D receptor 3′-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta. 1999;1453:311-320.
Rs739837 Polymorphism in MiR-885-3p Binding Site Within 3'-Untranslated Region of Vitamin D Receptor is Associated with a Decreased Risk of Pressure Ulcers
Published in Cell Physiol Biochem (2017).
Publication details
Ji X, Mao J, Zhou S. Rs739837 Polymorphism in MiR-885-3p Binding Site Within 3′-Untranslated Region of Vitamin D Receptor is Associated with a Decreased Risk of Pressure Ulcers. Cell Physiol Biochem. 2017;44:2129-2137.